ArticleOncology letters2017

The novel immunomodulator IMMUNEPOTENT CRP combined with chemotherapy agent increased the rate of immunogenic cell death and prevented melanoma growth.

Maria Del Carmen Rodríguez-Salazar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.